Skip to main content

Year: 2025

Vantage Drilling International Ltd. – Ex. Dividend USD 5 Today

Dubai, Dec. 17, 2025 (GLOBE NEWSWIRE) — The shares in Vantage Drilling International Ltd. will be traded ex dividend of USD 5 per ordinary share as of today, 17 December 2025. Issuer: Vantage Drilling International Ltd. Ex. date: 17 December 2025 Dividend amount: USD 5 per share Announced currency: USD This information is published in accordance with the requirements of the Continuing Obligations. About Vantage Drilling International Ltd. Vantage Drilling International Ltd., a Bermuda exempted company, is an offshore drilling contractor. Vantage Drilling’s primary business is to contract drilling units, related equipment and work crews primarily on a dayrate basis to drill oil and natural gas wells globally for major, national and independent oil and gas companies. Vantage Drilling also markets, operates and provides management...

Continue reading

Virtune Extends Partnership with Truls Möregårdh

Stockholm, December 17, 2025 – Virtune, a Swedish regulated crypto asset manager, is extending its collaboration with table tennis star Truls Möregårdh. After winning two Olympic silver medals in 2024 and defeating the world number one in the final of the major tournament WTT Europe Smash 2025, Truls enters the intense 2026 season with both energy and curiosity, qualities that also define Virtune’s view of the future. Virtune is a leading Swedish regulated crypto asset manager. The company has grown rapidly in the Nordic region and is now also expanding into the German market, with the ambition of providing both retail and professional investors with a safer and regulated way to invest in crypto assets. “I like working with Virtune because they dare to explore how investments can evolve in the future. That suits me and the way I want to...

Continue reading

Alvotech Successfully Places USD 108 Million Senior Unsecured Convertible Bonds in a Significantly Oversubscribed Offering

THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL OR DEMAND ADDITIONAL REGISTRATION OR OTHER MEASURES. PLEASE REFER TO “IMPORTANT INFORMATION” IN THE END OF THIS PRESS RELEASE. REYKJAVIK, ICELAND (December 17, 2025) — Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announces the successful placing of USD 108 million senior unsecured convertible bonds due 2030 (the “Offering”). The Offering, which was significantly oversubscribed, is undertaken...

Continue reading

Inbank Financial Calendar for 2026

AS Inbank hereby announces that the Financial Calendar for the 2026 financial year has been approved, setting out the planned dates for the disclosure of financial information and the Annual General Meeting of shareholders: 26.02.2026 Q4 and 2025 Full Year Unaudited Interim Report05.03.2026 2025 Audited Annual Report31.03.2026 Annual General Meeting30.04.2026 Q1 Interim Report30.07.2026 Q2 Interim Report29.10.2026 Q3 Interim Report Inbank is a financial technology company with an EU banking license that connects merchants, consumers and financial institutions on its next generation embedded finance platform. Partnering with more than 5,900 merchants, Inbank has 915,000+ active contracts and collects deposits across 7 markets in Europe. Inbank bonds are listed on the Nasdaq Tallinn Stock Exchange. Additional information:Styv SolovjovAS...

Continue reading

Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic

COPENHAGEN, Denmark, December 17, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that, following the recent appointment of Anne Louise Eberhard as new Chair of the Board of Directors, and in accordance with the Company’s Articles of Association, the Board has convened and has appointed Ms. Heidi Hunter as new Vice Chair. Ms. Hunter has been a member of the board since 2023. She has over 25 years of industry experience, working across the pharmaceutical value chain, from clinical and commercial development through to launch execution. She is formerly President at Cardinal Health, where she led the Specialty Solutions Businesses. Prior to Cardinal Health, Ms. Hunter held senior leadership positions at UCB, Boehringer Ingelheim, IQVIA and Centocor, a J&J company. She also led women’s health and oncology business at Wyeth (today...

Continue reading

Appointment of Laetitia Brun as Chief Human Resources Officer of the Eramet Group, member of the Executive Committee

Paris, December 17th, 2025, 8:30am PRESS RELEASE Appointment of Laetitia Brun as Chief Human Resources Officer of the Eramet Group, member of the Executive Committee Eramet announces the appointment of Laetitia Brun as Chief Human Resources Officer of the Group, effective February 9, 2026. In this capacity, she will become a member of the Executive Committee. She will succeed Anne-Marie Le Maignan, who has decided to retire after twenty-two years dedicated to supporting the Group’s development and its recent transformation into a pure player in mining and metals. Anne-Marie Le Maignan joined the Group in 2003 as Group Talents Director, before taking on successive HR leadership positions at entity and BU levels. In 2020, she was appointed Group Chief Human Resources Officer and member of the Executive Committee. Prior to joining Eramet,...

Continue reading

SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS

SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS A major partnership to accelerate Safe’s development in the Spanish market Fleurieux-sur-l’Arbresle – France – December 17, 2025 – 8am – Safe (FR001400ZU25 – ALSAF) announces the signing of an exclusive distribution agreement with Vortrom Biologics, a subsidiary of Vortrom, for the Spanish market. A strategic partnership with a leading player For more than 40 years, Vortrom, a major distributor of medical equipment in Spain, is now appointed exclusive partner of the Safe Group for the distribution of its surgical solutions throughout Spain. This strategic alliance is part of Safe’s commitment to accelerating its international expansion and strengthening its presence in key European markets by offering increasingly innovative solutions that meet...

Continue reading

Press release: Availability of the Q4 2025 Aide memoire

Availability of the Q4 2025 Aide memoire Paris, France – December 17, 2025. Sanofi announced today that its Q4 2025 Aide memoire is available on the “Investors” page of the company’s website: Fourth quarter & full year 2025 results (sanofi.com) As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group’s quarterly results. This document includes a reminder on various non-comparable items, as well as the foreign currency impact and share count. Sanofi’s fourth quarter & full year 2025 results will be published on January 29, 2026. About Sanofi Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines...

Continue reading

Exosens is awarded the EcoVadis Gold Medal, recognizing a commitment built over several years

EXOSENS IS AWARDED THE ECOVADIS GOLD MEDAL, RECOGNIZING A COMMITMENT BUILT OVER SEVERAL YEARS. PRESS RELEASEMÉRIGNAC, 17th DECEMBER 2025Exosens has been awarded the EcoVadis Gold Medal, placing the company among the top 5% of assessed organizations. With a score of 82/100, Exosens is a leader within the Aerospace & Defense sector. It recognizes the Group’s advanced CSR framework across four key areas: Environment, Social & Human Rights, Ethics, and Responsible Purchasing.Exosens, a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology, announces that it has been awarded the EcoVadis Gold Medal. This distinction attests to the robustness and maturity of the Group’s CSR framework. It also reflects the efforts undertaken since 2022 to strengthen ESG policies,...

Continue reading

Sampo plc’s share buybacks 16 December 2025

Sampo plc, stock exchange release, 17 December 2025 at 8:30 am EET Sampo plc’s share buybacks 16 December 2025 On 16 December 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  11,821 10.05 AQEU    98,289 10.05 CEUX  37,825 10.05 TQEX  111,942 10.05 XHELTOTAL 259,877 10.05  * rounded to two decimals                      On 5 November 2025, Sampo announced a share buyback programme of up to a maximum of EUR 150 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 6 November...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.